Devin Scannell Email Address

Senior Vice President, Drug Discovery and Executive Team Member

We are able to design and create new microbial strains at unprecedented scale and speed by automating every step of the process, removing guesswork and human error. Through precise measurement of each step in the process, we gain unparalleled insight into the workings of each new strain and the process at large. These designer microbes improve the economics of our customers' existing products and reveal paths forward, toward other new and useful products. From components in lightweight plastics to improved materials for patient health, this process has the capability to transform the impact of industrial biotechnology in businesses, the environment, and our lives.

Senior executive level strategy development and decision making in biotech, expertise in genetics and genomics (>1000 academic citations) and deep experience with advanced data analysis and computer programming. Interested in using technology to solve big problems in biology and health.